Skip to main content
. 2014 Apr 27;6(3):e14778. doi: 10.5812/numonthly.14778

Table 1. Study Groups, Mean Ages, Vascular Endothelial Growth Factor, Prostate-Specific Antigen, and Prostate Volume Values a, b.

Control BPH Cancer P value
Age, y 67.2 ± 7.2 68.7 ± 8.3 66.5 ± 9.1 0.38
40-59 7 (12.3) 6 (10.5) 9 (20.5)
60-69 26 (45.6) 25 (43.9) 24 (54.5)
≥ 70 24 (42.1) 26 (45.6) 11 (25)
VEGF, pg/mL 124.9 ± 50.8 147.5 ± 80 356.3 ± 181.1 < 0.001
PSA, ng/mL 1.94 ± 1.94 3.86 ± 2.3 38.7 ± 17.5 < 0.001
Prostate volume 37.4 ± 15.5 71.7 ± 25.5 < 0.001

a Abbreviations: BPH, benign prostate hyperplasia; PSA, prostate-specific antigen; VEGF, vascular endothelial growth factor.

bData are presented as mean ± SD or No. (%).